Stay updated on PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.

Latest updates to the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, a minor site version update that does not affect study content or user actions; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision metadata updated: Revision: v3.4.1 was added and Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 has been added and Revision: v3.4.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page update adds a Show glossary option and modifies several labels, including the QC status label wording/capitalization and the No FEAR Act text, plus a revision bump from v3.3.4 to v3.4.0. These changes are primarily UI/text updates and do not affect core study information.SummaryDifference0.1%

- Check42 days agoChange DetectedOnly a revision version update is shown (Revision: v3.3.4 added; Revision: v3.3.3 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedThe Locations section has been expanded to display a broad list of study sites across multiple countries and regions, with specific centers listed.SummaryDifference2%

Stay in the know with updates to PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.